2653519

Source:http://linkedlifedata.com/resource/pubmed/id/2653519

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002699, umls-concept:C0023449, umls-concept:C0023467, umls-concept:C0026259, umls-concept:C0087111, umls-concept:C0450442
pubmed:dateCreated	1989-6-12
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8702459
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Amsacrine, http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	0268-3369
pubmed:author	pubmed-author:ArlinZ AZA
pubmed:issnType	Print
pubmed:volume	4 Suppl 1
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	57-9
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:2653519-Amsacrine, pubmed-meshheading:2653519-Daunorubicin, pubmed-meshheading:2653519-Drug Evaluation, pubmed-meshheading:2653519-Humans, pubmed-meshheading:2653519-Leukemia, Myeloid, Acute, pubmed-meshheading:2653519-Mitoxantrone, pubmed-meshheading:2653519-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:2653519-Remission Induction
pubmed:year	1989
pubmed:articleTitle	Mitoxantrone and amsacrine: two important agents for the treatment of acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL).
pubmed:affiliation	New York Medical College, Valhalla.
pubmed:publicationType	Journal Article, Comparative Study, Review